Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials

These results indicate that in the absence of apical toxicity data, a tiered strategy beginning with short term, in vivo tissue transcriptomics profiling can effectively and efficiently screen new ENMs that have a higher probability of inducing pulmonary pathogenesis.